Empowered Funds’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
10,788
-308
-3% -$81K 0.02% 966
2026
Q1
$2.96M Buy
+11,096
New +$3M 0.02% 885
2025
Q4
Sell
-3,790
Closed -$1.09M 1504
2025
Q3
$1.09M Sell
3,790
-4,464
-54% -$1.2M 0.01% 1153
2025
Q2
$2.17M Buy
8,254
+616
+8% +$150K 0.02% 783
2025
Q1
$1.78M Sell
7,638
-387
-5% -$93.9K 0.03% 797
2024
Q4
$1.84M Buy
8,025
+43
+0.5% +$9.86K 0.03% 766
2024
Q3
$1.78M Buy
7,982
+608
+8% +$134K 0.03% 712
2024
Q2
$1.5M Buy
7,374
+2,921
+66% +$594K 0.03% 718
2024
Q1
$973K Buy
4,453
+2,893
+185% +$637K 0.02% 889
2023
Q4
$355K Buy
1,560
+284
+22% +$59.7K 0.01% 1071
2023
Q3
$257K Buy
1,276
+122
+11% +$25.7K 0.01% 1093
2023
Q2
$239K Buy
+1,154
New +$224K 0.01% 1025
2022
Q2
Sell
-19,255
Closed -$4.36M 309
2022
Q1
$4.36M Buy
19,255
+1,196
+7% +$281K 0.48% 67
2021
Q4
$4.88M Buy
18,059
+948
+6% +$235K 0.55% 65
2021
Q3
$4.14M Sell
17,111
-532
-3% -$134K 0.53% 65
2021
Q2
$4.18M Buy
+17,643
New +$4.02M 0.53% 49

Other funds holding LH

Empowered Funds's LH Position: Q2 2026 in Review

Empowered Funds reduced its Labcorp (LH) stake by 2.8% in Q2 2026, selling an estimated $81K and leaving 10,788 shares worth $3.02M. The position accounts for 0.02% of the portfolio, ranked #966.

Empowered Funds first reported a position in LH in Q2 2021 and has held it in 16 quarters since. The position peaked at $4.88M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Empowered Funds held 10,788 shares of Labcorp worth $3.02M as of Q2 2026.
  • Empowered Funds sold 308 Labcorp shares in Q2 2026, an estimated $81K.
  • Labcorp made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #966 holding.
  • Empowered Funds first reported a position in Labcorp in Q2 2021 and has held it in 16 quarters since.
  • Empowered Funds's Labcorp position peaked at $4.88M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.